Here are relevant reports on : dementia-care-device-market
-
Medical Device Outsourced Manufacturing Market by Device Type (IVD (Equipment, Consumable), Diabetes, Respiratory, Cardiovascular, Personal Care, Endoscopy, Dental, Ophthalmology, Devices) Class of Device, Services, Procedure - Forecast to 2026
The global medical device outsourced manufacturing market growth is primed to transition from $29.3 billion in 2021 to $56.2 billion by 2026, showcasing a strong CAGR of 13.9%. The medical device outsourced manufacturing market is mainly driven by the overall growth of the medical devices market, mainly due to the rising disease prevalence, life expectancy, and geriatric population. Technological advancements have prompted end users to overhaul or update their manufacturing systems.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting & Region - Global Forecast to 2029
The global mental health screening market, valued at US$0.8 billion in 2022, stood at US$0.9 billion in 2023 and is projected to advance at a resilient CAGR of 12.2% from 2023 to 2029, culminating in a forecasted valuation of US$1.8 billion by the end of the period. The growth of this market is driven by the rising awareness of mental health issues, growing geriatric population and subsequent increase in the prevalence of mental disorders, and technological advancements.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
North America Respiratory Care Device Market by Product (PAP Device, Ventilator, Humidifier, Oxygen Concentrator, Spirometer, Peak Flow Meter, Mask), Disease Indication (Asthma, Infectious Disease), End User (Hospital, Homecare Setting)-Forecast to 2031
The North America Respiratory Care Device market, valued at US$9.88 billion in 2025, stood at US$10.53 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$15.31 billion by the end of the period. The North America respiratory care devices market has been growing as the number of chronic respiratory diseases, such as COPD, asthma, and sleep apnea, continues to rise.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Wound Care Market by Product [Dressing (Foam, Hydrocolloid, Collagen), Device (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers)], Wound (Chronic, Acute), End User (Hospital, Clinic, Home Care), Region - Forecast to 2031
The asia pacific wound care market, valued at USD 6.04 billion in 2025, stood at USD 6.51 billion in 2026 and is projected to advance at a resilient CAGR of 8.2% from 2026 to 2031, culminating in a forecasted valuation of USD 9.69 billion by the end of the period. The market in the Asia Pacific region is expected to grow significantly in the coming years due to increasing rates of traumatic and burn injuries, higher prevalence of chronic conditions, and a rising population of older adults in this region.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
US Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Home Care Settings) - Forecast to 2031
The US Respiratory Care Devices market, valued at US$9.40 billion in 2025, stood at US$10.02 billion in 2026 and is projected to advance at a resilient CAGR of 7.8% from 2026 to 2031, culminating in a forecasted valuation of US$14.56 billion by the end of the period. This growth is primarily driven by an increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, along with an aging population that is more susceptible to breathing disorders.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cardiovascular Ultrasound System Market by Test Type (Transesophageal, Stress, Transthoracic, Fetal), Technology (2D, 3D & 4D, Doppler Imaging), Device Display (Black & White, Color), End User (Hospitals, Home Care, Ambulatory)- Global Forecast to 2022
The global cardiovascular ultrasound system market size is projected to grow at a CAGR of 5.4%. The market is segmented on the basis of test type, technology, device display, end user, and region. Based on test type, the market is categorized into transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other echocardiograms. The other echocardiograms include fetal & intracardiac echocardiograms.
- Published: December 2016
- Price: $ 4950
- TOC Available:
-
Medical Engineered Materials Market by Type (Medical plastics, medical foams, medical films, medical elastomers, medical adhesives), Application (Medical device, disposables, medical wearables, advanced wound care), and Region - Global Forecast to 2025
The Medical Engineered Materials Market is expected to grow from USD 15.8 billion in 2020 to USD 29.1 billion by 2025, at a CAGR of 13.0% during the forecast period. The key players in the medical engineered materials market include Evonik (Germany), Covestro (Germany), BASF (Germany), Solvay (Belgium), SABIC (Saudi Arabia), Trelleborg AB (Sweden), DSM (Netherlands), Celanese (US), and DuPont (US). These players have established a strong foothold in the market by adopting strategies, such as investment & expansion, merger & acquisition, agreement & collaboration, partnership, new product launch.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at USD 633.77 billion in 2024, stood at USD 690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of USD 1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of US$379.17 billion by the end of the period. The increasing prevalence of chronic diseases worldwide, coupled with the introduction and approval of innovative advanced therapeutics, is driving significant market expansion.
- Published: May 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
